Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Differentiation between basal cell carcinoma and trichoepithelioma by immunohistochemical staining of the androgen receptor: an overview.

Arits AH, Van Marion AM, Lohman BG, Thissen MR, Steijlen PM, Nelemans PJ, Kelleners-Smeets NW.

Eur J Dermatol. 2011 Nov-Dec;21(6):870-3. doi: 10.1684/ejd.2011.1504.

PMID:
21865121
2.

PHLDA1 (TDAG51) is a follicular stem cell marker and differentiates between morphoeic basal cell carcinoma and desmoplastic trichoepithelioma.

Sellheyer K, Krahl D.

Br J Dermatol. 2011 Jan;164(1):141-7. doi: 10.1111/j.1365-2133.2010.10045.x. Epub 2010 Dec 6.

PMID:
20846311
3.

Elastic fiber staining and cytokeratin 15 expression pattern in trichoepithelioma and basal cell carcinoma.

Choi CW, Park HS, Kim YK, Lee SH, Cho KH.

J Dermatol. 2008 Aug;35(8):499-502. doi: 10.1111/j.1346-8138.2008.00510.x.

PMID:
18789069
4.

Androgen receptor expression helps to differentiate basal cell carcinoma from benign trichoblastic tumors.

Izikson L, Bhan A, Zembowicz A.

Am J Dermatopathol. 2005 Apr;27(2):91-5.

PMID:
15798431
5.

Advanced differentiation in trichoepithelioma and basal cell carcinoma investigated by immunohistochemistry against neurofilaments.

Fernandez-Flores A.

Folia Histochem Cytobiol. 2009;47(1):61-4. doi: 10.2478/v10042-009-0011-5.

6.

Does the panel of cytokeratin 20 and androgen receptor antibodies differentiate desmoplastic trichoepithelioma from morpheaform/infiltrative basal cell carcinoma?

Katona TM, Perkins SM, Billings SD.

J Cutan Pathol. 2008 Feb;35(2):174-9. doi: 10.1111/j.1600-0560.2007.00783.x.

PMID:
18190441
7.

CD10 expression in trichoepithelioma and basal cell carcinoma.

Pham TT, Selim MA, Burchette JL Jr, Madden J, Turner J, Herman C.

J Cutan Pathol. 2006 Feb;33(2):123-8.

PMID:
16420307
8.

Fibroblast-activation protein: a single marker that confidently differentiates morpheaform/infiltrative basal cell carcinoma from desmoplastic trichoepithelioma.

Abbas O, Richards JE, Mahalingam M.

Mod Pathol. 2010 Nov;23(11):1535-43. doi: 10.1038/modpathol.2010.142. Epub 2010 Aug 13.

9.

Diagnostic utility of immunohistochemistry in distinguishing trichoepithelioma and basal cell carcinoma: evaluation using tissue microarray samples.

Tebcherani AJ, de Andrade HF Jr, Sotto MN.

Mod Pathol. 2012 Oct;25(10):1345-53. doi: 10.1038/modpathol.2012.96. Epub 2012 Jun 8.

10.

Immunohistochemical evaluation of basal cell carcinoma and trichepithelioma using Bcl-2, Ki67, PCNA and P53.

Abdelsayed RA, Guijarro-Rojas M, Ibrahim NA, Sangueza OP.

J Cutan Pathol. 2000 Apr;27(4):169-75.

PMID:
10774937
11.

Expression of p27kip1 in basal cell carcinomas and trichoepitheliomas.

Cesinaro AM, Migaldi M, Corrado S, Maiorana A.

Am J Dermatopathol. 2002 Aug;24(4):313-8.

PMID:
12142610
12.

Microcystic adnexal carcinoma: an immunohistochemical reappraisal.

Hoang MP, Dresser KA, Kapur P, High WA, Mahalingam M.

Mod Pathol. 2008 Feb;21(2):178-85. Epub 2007 Dec 7.

13.

Desmoplastic trichoepithelioma versus morphoeic basal cell carcinoma: a critical reappraisal of histomorphological and immunohistochemical criteria for differentiation.

Costache M, Bresch M, Böer A.

Histopathology. 2008 Jun;52(7):865-76. doi: 10.1111/j.1365-2559.2008.03036.x. Epub 2008 May 6.

PMID:
18462369
15.

Significance of androgen receptor and CD10 expression in cutaneous basal cell carcinoma and trichoepithelioma.

Astarci HM, Gurbuz GA, Sengul D, Hucumenoglu S, Kocer U, Ustun H.

Oncol Lett. 2015 Dec;10(6):3466-3470. Epub 2015 Oct 13.

16.

The immunohistochemical differential diagnosis of microcystic adnexal carcinoma, desmoplastic trichoepithelioma and morpheaform basal cell carcinoma using BerEP4 and stem cell markers.

Sellheyer K, Nelson P, Kutzner H, Patel RM.

J Cutan Pathol. 2013 Apr;40(4):363-70. doi: 10.1111/cup.12085. Epub 2013 Feb 11.

PMID:
23398472
17.

Trichoepithelioma: a 19-year clinicopathologic re-evaluation.

Bettencourt MS, Prieto VG, Shea CR.

J Cutan Pathol. 1999 Sep;26(8):398-404.

PMID:
10551412
18.

Molecular diagnosis of basal cell carcinoma and other basaloid cell neoplasms of the skin by the quantification of Gli1 transcript levels.

Hatta N, Hirano T, Kimura T, Hashimoto K, Mehregan DR, Ansai S, Takehara K, Takata M.

J Cutan Pathol. 2005 Feb;32(2):131-6.

PMID:
15606671
19.

Immunohistochemical analysis of the mechanistic target of rapamycin and hypoxia signalling pathways in basal cell carcinoma and trichoepithelioma.

Brinkhuizen T, Weijzen CA, Eben J, Thissen MR, van Marion AM, Lohman BG, Winnepenninckx VJ, Nelemans PJ, van Steensel MA.

PLoS One. 2014 Sep 2;9(9):e106427. doi: 10.1371/journal.pone.0106427. eCollection 2014.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk